These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 8821850
1. Maternal serum screening for fetal Down syndrome in IVF pregnancies. Ribbert LS, Kornman LH, De Wolf BT, Simons AH, Jansen CA, Beekhuis JR, Mantingh A. Prenat Diagn; 1996 Jan; 16(1):35-8. PubMed ID: 8821850 [Abstract] [Full Text] [Related]
2. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD, McIntosh SF, Halstead AC. Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [Abstract] [Full Text] [Related]
4. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA. Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [Abstract] [Full Text] [Related]
8. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay. Talbot JA, Spencer K, Abushoufa RA. Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803 [Abstract] [Full Text] [Related]
10. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome]. Liao S, Wang Y, Ye G. Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764 [Abstract] [Full Text] [Related]
11. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome. Muller F, Dreux S, Lemeur A, Sault C, Desgrès J, Bernard MA, Giorgetti C, Lemay C, Mirallié S, Beauchet A, French Collaborative Group. Prenat Diagn; 2003 Dec 30; 23(13):1073-6. PubMed ID: 14691995 [Abstract] [Full Text] [Related]
12. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG. Eloranta ML, Heinonen S, Kirkinen P. Acta Obstet Gynecol Scand; 2000 Jul 30; 79(7):548-52. PubMed ID: 10929953 [Abstract] [Full Text] [Related]
16. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Wald NJ, Watt HC. Prenat Diagn; 1996 Aug 30; 16(8):699-703. PubMed ID: 8878278 [Abstract] [Full Text] [Related]
17. 46,XY,i(21q) identified by maternal serum screening. Meyers CM, Ghori S, Roberson AE, Blitzer MG, Cohen MM. Md Med J; 1997 Feb 30; 46(2):88-9. PubMed ID: 9029908 [Abstract] [Full Text] [Related]
18. Triploidy identified through second-trimester serum screening. Huang T, Alberman E, Wald N, Summers AM. Prenat Diagn; 2005 Mar 30; 25(3):229-33. PubMed ID: 15791661 [Abstract] [Full Text] [Related]
19. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies. Jauniaux E, Gulbis B, Tunkel S, Ramsay B, Campbell S, Meuris S. Prenat Diagn; 1996 Dec 30; 16(12):1129-35. PubMed ID: 8994249 [Abstract] [Full Text] [Related]
20. Maternal serum markers levels in consecutive pregnancies: a possible genetic predisposition to abnormal levels. Dar H, Merksamer R, Berdichevsky D, David M. Am J Med Genet; 1996 Jan 11; 61(2):154-7. PubMed ID: 8669443 [Abstract] [Full Text] [Related] Page: [Next] [New Search]